Nerve Solutions Inc.


Our patent-pending implantable platform device contains a biomaterial scaffold that can prevent debilitating pain from neuromas. The same device, when mixed with a cocktail of growth factors aids repair of large nerve gaps for trauma patients. Around 500,000 patients in the US currently have neuromas with treatment failure rates of 20-30% ($1.3B market potential). Annual incidence of large gap nerve injuries is $170,000 ($1B market potential).

Management Team

Anil Achyuta